$3.51
-0.01-0.28%
Pre-Market: 8:45 AM EDT
15 minutes delayed
ImmunityBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ImmunityBio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.20 | $-0.17 | -17.6 % |
Mar 2024 | 2024-05-09 | $-0.20 | $-0.16 | -25.0 % |
Dec 2023 | 2024-03-19 | $-0.38 | $-0.18 | -111.1 % |
Sep 2023 | 2023-11-09 | $-0.19 | $-0.27 | 29.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $1.05M | $2.52M | -58.5 % |
Mar 2024 | 2024-05-09 | $40.00K | $20.00K | 100.0 % |
Dec 2023 | 2024-03-19 | $139.00K | $20.00K | 595.0 % |
Sep 2023 | 2023-11-09 | $82.00K | $30.00K | 173.3 % |
ImmunityBio (IBRX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.20, which missed the estimate of $-0.17.
The Actual Revenue was $1M, which missed the estimate of $2.5M.
Browse earnings estimates, EPS, and revenue on all stocks.